- Home
- PODD
PODD
Insulet Corporation
as 08-26-2025 4:00pm EST
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | ACTON |
| Market Cap: | 21.5B | IPO Year: | 2007 |
| Target Price: | $332.22 | AVG Volume (30 days): | 697.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 18 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.32 | EPS Growth: | -38.92 |
| 52 Week Low/High: | $180.31 - $334.18 | Next Earning Date: | 08-07-2025 |
| Revenue: | $2,359,500,000 | Revenue Growth: | 26.00% |
| Revenue Growth (this year): | 24.54% | Revenue Growth (next year): | 17.48% |
Stock Insider Trading Activity of Insulet Corporation (PODD)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Manea Dan | PODD | SVP, Chief HR Officer | Jun 13 '25 | Sell | $300.05 | 1,300 | $390,065.00 | 9,090 | |
| BORIO LUCIANA | PODD | Director | Jun 9 '25 | Sell | $305.73 | 481 | $147,056.13 | 3,087 |
Latest Insulet Corporation News
PODD Breaking Stock News: Dive into PODD Ticker-Specific Updates for Smart Investing
Zacks
4 days ago
Insulet Gains 77.2% in a Year: What's Driving the Rally?
Investor's Business Daily
5 days ago
Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating
MT Newswires
5 days ago
Barclays Adjusts Price Target on Insulet to $300 From $266, Maintains Equalweight Rating
Investor's Business Daily
6 days ago
Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares.
Investor's Business Daily
6 days ago
Dow Jones Futures: Palantir, Oracle, Other Growth Leaders Keep Falling; What To Do Now
Investor's Business Daily
7 days ago
Insulet Stock Breaks Out — Again — As Momentum Continues
Business Wire
8 days ago
Insulet to Participate in Upcoming Investor Conferences
TipRanks
2 months ago
Diabetes stocks rally after RFK comments on HHS campaign
Compare PODD vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PODD Insulet Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.